TY - JOUR
T1 - Clinical and dosimetric considerations for Y90
T2 - recommendations from an international multidisciplinary working group
AU - Salem, Riad
AU - Padia, Siddharth A.
AU - Lam, Marnix
AU - Bell, Jon
AU - Chiesa, Carlo
AU - Fowers, Kirk
AU - Hamilton, Bonnie
AU - Herman, Joseph
AU - Kappadath, S. Cheenu
AU - Leung, Thomas
AU - Portelance, Lorraine
AU - Sze, Daniel
AU - Garin, Etienne
PY - 2019/7/1
Y1 - 2019/7/1
N2 - The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.
AB - The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.
KW - Hepatocellular carcinoma
KW - Liver cancer
KW - Radioembolization
KW - Yttrium-90
UR - http://www.scopus.com/inward/record.url?scp=85066012938&partnerID=8YFLogxK
U2 - 10.1007/s00259-019-04340-5
DO - 10.1007/s00259-019-04340-5
M3 - Article
C2 - 31098749
AN - SCOPUS:85066012938
SN - 1619-7070
VL - 46
SP - 1695
EP - 1704
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
IS - 8
ER -